Skip to main content
SpringerLink
Log in

Fibromyalgia and Myofascial Pain

  • Chapter
  • First Online:
Pain in Women

  • 1486 Accesses

Abstract

The soft tissue pain syndromes are among the most nebulous and yet arguably most prevalent conditions encountered in pain medicine. Although not progressive, degenerative, or life threatening in their effects, they can cause significant pain and functional limitations for patients. In addition, because of the absence of imaging findings or other objective diagnostic testing available, the diagnosis (and often treatment) of these conditions is highly dependent on the clinical skills of the clinician. Therefore, it is vital that the clinician seeing patients with pain issues be comfortable with the evaluation and management of patients with these disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Arnold LM. The pathophysiology, diagnosis and treatment of fibromyalgia. Psychiatr Clin North Am. 2010;33(2):375–408.

    Article  PubMed  Google Scholar 

  2. Balfour GW. Observations on the pathology and cure of rheumatism. Edinburgh Med Surg J. 1815;15:168–87.

    Google Scholar 

  3. Scudamore C. A treatise on the nature and cure of rheumatism. London: Longmans, Rees, Orme, Brown and Green; 1827.

    Google Scholar 

  4. Gowers WR. A lecture on lumbago: its lessons and analogues: delivered at the national hospital for the paralysed and epileptic. Br Med J. 1904;1(2246):117–21.

    Article  PubMed  CAS  Google Scholar 

  5. Hudson JI, Pope Jr HG. Fibromyalgia and psychopathology: is fibromyalgia a form of “affective spectrum disorder”? J Rheumatol. 1989;19(Suppl):15–22.

    CAS  Google Scholar 

  6. Hudson JI, Pope HG. The concept of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain. Baillieres Clin Rheumatol. 1994;8(4):839–56.

    Article  PubMed  CAS  Google Scholar 

  7. Yunus MB. Primary fibromyalgia syndrome: current concepts. Compr Ther. 1984;10(8):21–8.

    PubMed  CAS  Google Scholar 

  8. Yunus MB. Role of central sensitization in symptoms beyond muscle pain, and the evaluation of a patient with widespread pain. Best Pract Res Clin Rheumatol. 2007;21(3):481–97.

    Article  PubMed  Google Scholar 

  9. Ablin K, Clauw DJ. From fibrositis to functional somatic syndromes to a bell-shaped curve of pain and sensory sensitivity: evolution of a clinical construct. Rheum Dis Clin North Am. 2009;35(2):233–51.

    Article  PubMed  Google Scholar 

  10. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004;292(19):2388–95.

    Article  PubMed  CAS  Google Scholar 

  11. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38(1):19–28.

    Article  PubMed  CAS  Google Scholar 

  12. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62(5):600–10.

    Article  Google Scholar 

  13. Wolfe F, Ross K, Anderson J, Russell IJ. Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol. 1995;22(1):151–6.

    PubMed  CAS  Google Scholar 

  14. Aaron LA, Buchwald D. Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. Best Pract Res Clin Rheumatol. 2003;17(4):563–74.

    Article  PubMed  Google Scholar 

  15. Okifuji A, Bradshaw DH, Olson C. Evaluating obesity in fibromyalgia: neuroendocrine ­biomarkers, symptoms, and functions. Clin Rheumatol. 2009;28(4):475–8.

    Article  PubMed  Google Scholar 

  16. Moldofsky H. Management of sleep disorders in fibromyalgia. Rheum Dis Clin North Am. 2002;28(2):353–65.

    Article  PubMed  Google Scholar 

  17. Muller W, Lautenschlager J. Generalized tendomyopathy. I: clinical aspects, follow-up and differential diagnosis. Z Rheumatol. 1990;49(1):11–21.

    PubMed  CAS  Google Scholar 

  18. Petzke F, Clauw DJ, Ambrose K, Khine A, Gracely RH. Increased pain sensitivity in fibromyalgia: effects of stimulus type and mode of presentation. Pain. 2003;105(3):403–13.

    Article  PubMed  Google Scholar 

  19. Kosek E, Ekholm J, Hansson P. Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain. 1996;68(2–3):375–83.

    Article  PubMed  CAS  Google Scholar 

  20. Arroyo JF, Cohen ML. Abnormal responses to electrocutaneous stimulation in fibromyalgia. J Rheumatol. 1993;20(11):1925–31.

    PubMed  CAS  Google Scholar 

  21. Wolfe F. The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis. 1997;56(4): 268–71.

    Article  PubMed  CAS  Google Scholar 

  22. Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Javaras KN, Hess EV. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry. 2006;67(8):1219–25.

    Article  PubMed  Google Scholar 

  23. Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, et al. Family study of fibromyalgia. Arthritis Rheum. 2004;50(3):944–52.

    Article  PubMed  Google Scholar 

  24. Kato K, Sullivan PF, Evengard B, Pedersen NL. Importance of genetic influences on chronic widespread pain. Arthritis Rheum. 2006;54(5):1682–6.

    Article  PubMed  CAS  Google Scholar 

  25. Benjamin S, Morris S, McBeth J, Macfarlane GJ, Silman AJ. The association between chronic widespread pain and mental disorder: a population-based study. Arthritis Rheum. 2000;43(3):561–7.

    Article  PubMed  CAS  Google Scholar 

  26. McBeth J, Silman AJ. The role of psychiatric disorders in fibromyalgia. Curr Rheumatol Rep. 2001;3(2):157–64.

    Article  PubMed  CAS  Google Scholar 

  27. Kersh BC, Bradley LA, Alarcon GS, Alberts KR, Sotolongo A, Martin MY, et al. Psychosocial and health status variables independently predict health care seeking in fibromyalgia. Arthritis Rheum. 2001;45(4):362–71.

    Article  PubMed  CAS  Google Scholar 

  28. McLean SA, Clauw DJ. Predicting chronic symptoms after an acute “stressor” – lessons learned from 3 medical conditions. Med Hypotheses. 2004;63(4):653–8.

    Article  PubMed  Google Scholar 

  29. McEwen BS. Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann N Y Acad Sci. 2001;933:265–77.

    Article  PubMed  CAS  Google Scholar 

  30. McEwen BS, Kalia M. The role of corticosteroids and stress in chronic pain conditions. Metabolism. 2010;59 Suppl 1:S9–15.

    Article  PubMed  CAS  Google Scholar 

  31. Di Franco M, Iannuccelli C, Valesini G. Neuroendocrine immunology of fibromyalgia. Ann N Y Acad Sci. 2010;1193(1):84–90.

    Article  PubMed  CAS  Google Scholar 

  32. McEwen BS. Introduction: the end of sex as we once knew it. Physiol Behav. 2009;97(2):143–5.

    Article  PubMed  CAS  Google Scholar 

  33. McLean SA, Williams DA, Stein PK, Harris RE, Lyden AK, Whalen G, et al. Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia. Neuropsychopharmacology. 2006;31(12):2776–82.

    Article  PubMed  CAS  Google Scholar 

  34. Diatchenko L, Nackley AG, Slade GD, Bhalang K, Belfer I, Max MB, et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain. 2006;125(3):216–24.

    Article  PubMed  CAS  Google Scholar 

  35. Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I, et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet. 2005;14(1):135–43.

    Article  PubMed  CAS  Google Scholar 

  36. Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, Schwarz M, et al. The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol Dis. 1999;6(5): 433–9.

    Article  PubMed  CAS  Google Scholar 

  37. Buskila D, Cohen H, Neumann L, Ebstein RP. An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits. Mol Psychiatry. 2004;9(8):730–1.

    Article  PubMed  CAS  Google Scholar 

  38. Buskila D, Sarzi-Puttini P, Ablin JN. The genetics of fibromyalgia syndrome. Pharmacogenomics. 2007;8(1):67–74.

    Article  PubMed  CAS  Google Scholar 

  39. Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B, Erdal N. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int. 2003;23(3):104–7.

    PubMed  Google Scholar 

  40. Russell IJ, Larson AA. Neurophysiopathogenesis of fibromyalgia syndrome: a unified hypothesis. Rheum Dis Clin North Am. 2009;35(2):421–35.

    Article  PubMed  Google Scholar 

  41. Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum. 2002;46(5):1333–43.

    Article  PubMed  Google Scholar 

  42. Harris RE, Clauw DJ, Scott DJ, McLean SA, Gracely RH, Zubieta JK. Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci. 2007;27(37):10000–6.

    Article  PubMed  CAS  Google Scholar 

  43. Wallace DJ, Margolin K, Waller P. Fibromyalgia and interleukin-2 therapy for malignancy. Ann Intern Med. 1988;108(6):909.

    PubMed  CAS  Google Scholar 

  44. Wang H, Buchner M, Moser MT, Daniel V, Schiltenwolf M. The role of IL-8 in patients with fibromyalgia: a prospective longitudinal study of 6 months. Clin J Pain. 2009;25(1):1–4.

    Article  PubMed  Google Scholar 

  45. Goldenberg DL. Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Curr Opin Rheumatol. 1991;3(2):247–58.

    Article  PubMed  CAS  Google Scholar 

  46. Travell JG, Simons DG. Myofascial pain and dysfunction: the trigger point manual: the upper extremities. 1st ed. Baltimore: Williams & Wilkins; 1983.

    Google Scholar 

  47. Gerwin RD, Shannon S, Hong CZ, Hubbard D, Gevirtz R. Interrater reliability in myofascial trigger point examination. Pain. 1997;69(1–2):65–73.

    Article  PubMed  CAS  Google Scholar 

  48. Fishbain DA, Goldberg M, Meagher BR, Steele R, Rosomoff H. Male and female chronic pain patients categorized by DSM-III psychiatric diagnostic criteria. Pain. 1986;26(2):181–97.

    Article  PubMed  CAS  Google Scholar 

  49. Hsueh TC, Yu S, Kuan TS, Hong CZ. Association of active myofascial trigger points and cervical disc lesions. J Formos Med Assoc. 1998;97(3):174–80.

    PubMed  CAS  Google Scholar 

  50. Bajaj P, Bajaj P, Graven-Nielsen T, Arendt-Nielsen L. Trigger points in patients with lower limb osteoarthritis. J Musculoskelet Pain. 2001;9(3):17–33.

    Article  Google Scholar 

  51. Kleier DJ. Referred pain from a myofascial trigger point mimicking pain of endodontic origin. J Endod. 1985;11(9):408–11.

    Article  PubMed  CAS  Google Scholar 

  52. Ling FW, Slocumb JC. Use of trigger point injections in chronic pelvic pain. Obstet Gynecol Clin North Am. 1993;20(4):809–15.

    PubMed  CAS  Google Scholar 

  53. Mennell J. Myofascial trigger points as a cause of headaches. J Manipulative Physiol Ther. 1989;12(4):308–13.

    PubMed  CAS  Google Scholar 

  54. Kellgren JH. Referred pains from muscle. Br Med J. 1938;1(4023):325–7.

    Article  PubMed  CAS  Google Scholar 

  55. De Stefano R, Selvi E, Villanova M, Frati E, Manganelli S, Franceschini E, et al. Image analysis quantification of substance P immunoreactivity in the trapezius muscle of patients with fibromyalgia and myofascial pain syndrome. J Rheumatol. 2000;27(12):2906–10.

    PubMed  Google Scholar 

  56. Sprott H, Bradley LA, Oh SJ, Wintersberger W, Alarcon GS, Mussell HG, et al. Immunohistochemical and molecular studies of serotonin, substance P, galanin, pituitary adenylyl cyclase-activating polypeptide, and secretoneurin in fibromyalgic muscle tissue. Arthritis Rheum. 1998;41(9):1689–94.

    Article  PubMed  CAS  Google Scholar 

  57. Shah JP, Phillips TM, Danoff JV, Gerber LH. An in vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle. J Appl Physiol. 2005;99(5): 1977–84.

    Article  PubMed  CAS  Google Scholar 

  58. Lin Q, Zou X, Willis WD. A delta and C primary afferents convey dorsal root reflexes after intradermal injection of capsaicin in rats. J Neurophysiol. 2000;84(5):2695–8.

    PubMed  CAS  Google Scholar 

  59. Wang J, Ren Y, Zou X, Fang L, Willis WD, Lin Q. Sympathetic influence on capsaicin-evoked enhancement of dorsal root reflexes in rats. J Neurophysiol. 2004;92(4):2017–26.

    Article  PubMed  Google Scholar 

  60. Weng HR, Dougherty PM. Response properties of dorsal root reflexes in cutaneous C fibers before and after intradermal capsaicin injection in rats. Neuroscience. 2005;132(3):823–31.

    Article  PubMed  CAS  Google Scholar 

  61. Peng HY, Chen GD, Tung KC, Lai CY, Hsien MC, Chiu CH, et al. Colon mustard oil instillation induced cross-organ reflex sensitization on the pelvic-urethra reflex activity in rats. Pain. 2009;142(1–2):75–88.

    Article  PubMed  CAS  Google Scholar 

  62. Holzer P. Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol. 1998;30(1):5–11.

    Article  PubMed  CAS  Google Scholar 

  63. Willis Jr WD. Dorsal root potentials and dorsal root reflexes: a double-edged sword. Exp Brain Res. 1999;124(4):395–421.

    Article  PubMed  CAS  Google Scholar 

  64. Habler HJ, Wasner G, Janig W. Interaction of sympathetic vasoconstriction and antidromic vasodilatation in the control of skin blood flow. Exp Brain Res. 1997;113(3):402–10.

    Article  PubMed  CAS  Google Scholar 

  65. Magerl W, Koltzenburg M, Schmitz JM, Handwerker HO. Asymmetry and time-course of cutaneous sympathetic reflex responses following sustained excitation of chemosensitive nociceptors in humans. J Auton Nerv Syst. 1996;57(1–2):63–72.

    Article  PubMed  CAS  Google Scholar 

  66. Mense S. The pathogenesis of muscle pain. Curr Pain Headache Rep. 2003;7(6):419–25.

    Article  PubMed  Google Scholar 

  67. Shah JP, Danoff JV, Desai MJ, Parikh S, Nakamura LY, Phillips TM, et al. Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points. Arch Phys Med Rehabil. 2008;89(1):16–23.

    Article  PubMed  Google Scholar 

  68. Gerwin RD. A review of myofascial pain and fibromyalgia – factors that promote their persistence. Acupunct Med. 2005;23(3):121–34.

    Article  PubMed  Google Scholar 

  69. Wall PD, Woolf CJ. Muscle but not cutaneous C-afferent input produces prolonged increases in the excitability of the flexion reflex in the rat. J Physiol. 1984;356:443–58.

    PubMed  CAS  Google Scholar 

  70. Hoheisel U, Mense S, Simons DG, Yu XM. Appearance of new receptive fields in rat dorsal horn neurons following noxious stimulation of skeletal muscle: a model for referral of muscle pain? Neurosci Lett. 1993;153(1):9–12.

    Article  PubMed  CAS  Google Scholar 

  71. Woda A, Pionchon P. A unified concept of idiopathic orofacial pain: pathophysiologic features. J Orofac Pain. 2000;14(3):196–212.

    PubMed  CAS  Google Scholar 

  72. Pohjolainen T. A clinical evaluation of stumps in lower limb amputees. Prosthet Orthot Int. 1991;15(3):178–84.

    PubMed  CAS  Google Scholar 

  73. Miller MH, Topliss DJ. Chronic upper limb pain syndrome (repetitive strain injury) in the Australian workforce: a systematic cross sectional rheumatological study of 229 patients. J Rheumatol. 1988;15(11):1705–12.

    PubMed  CAS  Google Scholar 

  74. Coderre TJ, Xanthos DN, Francis L, Bennett GJ. Chronic post-ischemia pain (CPIP): a novel animal model of complex regional pain syndrome-type I (CRPS-I; reflex sympathetic dystrophy) produced by prolonged hindpaw ischemia and reperfusion in the rat. Pain. 2004;112(1–2):94–105.

    Article  PubMed  Google Scholar 

  75. Shenker NG, Haigh RC, Mapp PI, Harris N, Blake DR. Contralateral hyperalgesia and allodynia following intradermal capsaicin injection in man. Rheumatology (Oxford). 2008;47(9):1417–21.

    Article  CAS  Google Scholar 

  76. Audette JF, Wang F, Smith H. Bilateral activation of motor unit potentials with unilateral needle stimulation of active myofascial trigger points. Am J Phys Med Rehabil. 2004;83(5):368–74. quiz 375–7, 389.

    Article  PubMed  Google Scholar 

  77. Koltzenburg M. The changing sensitivity in the life of the nociceptor. Pain. 1999;82 Suppl 6:S93–102.

    Article  Google Scholar 

  78. Chacur M, Milligan ED, Gazda LS, Armstrong C, Wang H, Tracey KJ, et al. A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats. Pain. 2001;94(3):231–44.

    Article  PubMed  CAS  Google Scholar 

  79. Watkins LR, Maier SF. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev. 2002;82(4):981–1011.

    PubMed  CAS  Google Scholar 

  80. van Rijn MA, Marinus J, Putter H, Bosselaar SR, Moseley GL, van Hilten JJ. Spreading of complex regional pain syndrome: not a random process. J Neural Transm. 2011;118:1301.

    Article  PubMed  Google Scholar 

  81. Cummings TM, White AR. Needling therapies in the management of myofascial trigger point pain: a systematic review. Arch Phys Med Rehabil. 2001;82(7):986–92.

    Article  PubMed  CAS  Google Scholar 

  82. Ceccheerelli F, Bordin M, Gagliardi G, Caravello M. Comparison between superficial and deep acupuncture in the treatment of the shoulder’s myofascial pain: a randomized and controlled study. Acupunct Electrother Res. 2001;26(4):229–38.

    PubMed  CAS  Google Scholar 

  83. Ceccherelli F, Rigoni MT, Gagliardi G, Ruzzante L. Comparison of superficial and deep acupuncture in the treatment of lumbar myofascial pain: a double-blind randomized controlled study. Clin J Pain. 2002;18(3):149–53.

    Article  PubMed  Google Scholar 

  84. Irnich D, Behrens N, Gleditsch JM, Stor W, Schreiber MA, Schops P, et al. Immediate effects of dry needling and acupuncture at distant points in chronic neck pain: results of a randomized, double-blind, sham-controlled crossover trial. Pain. 2002;99(1–2):83–9.

    Article  PubMed  Google Scholar 

  85. Ga H, Choi JH, Park CH, Yoon HJ. Acupuncture needling versus lidocaine injection of trigger points in myofascial pain syndrome in elderly patients – a randomised trial. Acupunct Med. 2007;25(4):130–6.

    Article  PubMed  Google Scholar 

  86. Ay S, Evcik D, Tur BS. Comparison of injection methods in myofascial pain syndrome: a randomized controlled trial. Clin Rheumatol. 2010;29(1):19–23.

    Article  PubMed  Google Scholar 

  87. Itoh K, Katsumi Y, Kitakoji H. Trigger point acupuncture treatment of chronic low back pain in elderly patients – a blinded RCT. Acupunct Med. 2004;22(4):170–7.

    Article  PubMed  Google Scholar 

  88. Fine PG, Milano R, Hare BD. The effects of myofascial trigger point injections are naloxone reversible. Pain. 1988;32(1):15–20.

    Article  PubMed  CAS  Google Scholar 

  89. Farber L, Stratz TH, Bruckle W, Spath M, Pongratz D, Lautenschlager J, et al. Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients. Int J Clin Pharmacol Res. 2001;21(1):1–13.

    PubMed  CAS  Google Scholar 

  90. Muller W, Stratz T. Local treatment of tendinopathies and myofascial pain syndromes with the 5-HT3 receptor antagonist tropisetron. Scand J Rheumatol Suppl. 2004;119:44–8.

    Article  PubMed  CAS  Google Scholar 

  91. Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology. 2005;26(5):785–93.

    Article  PubMed  CAS  Google Scholar 

  92. Favre-Guilmard C, Auguet M, Chabrier PE. Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models. Eur J Pharmacol. 2009;617(1–3):48–53.

    Article  PubMed  CAS  Google Scholar 

  93. Ferrante FM, Bearn L, Rothrock R, King L. Evidence against trigger point injection technique for the treatment of cervicothoracic myofascial pain with botulinum toxin type A. Anesthesiology. 2005;103(2):377–83.

    Article  PubMed  CAS  Google Scholar 

  94. Ojala T, Arokoski JP, Partanen J. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial. Clin J Pain. 2006;22(1):90–6.

    Article  PubMed  Google Scholar 

  95. Graboski CL, Gray DS, Burnham RS. Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study. Pain. 2005;118(1–2):170–5.

    Article  PubMed  CAS  Google Scholar 

  96. Gam AN, Warming S, Larsen LH, Jensen B, Hoydalsmo O, Allon I, et al. Treatment of myofascial trigger-points with ultrasound combined with massage and exercise – a randomised controlled trial. Pain. 1998;77(1):73–9.

    Article  PubMed  CAS  Google Scholar 

  97. Kruger LR, van der Linden WJ, Cleaton-Jones PE. Transcutaneous electrical nerve stimulation in the treatment of myofascial pain dysfunction. S Afr J Surg. 1998;36(1):35–8.

    PubMed  CAS  Google Scholar 

  98. Okumus M, Ceceli E, Tuncay F, Kocaoglu S, Palulu N, Yorgancioglu ZR. The relationship between serum trace elements, vitamin B12, folic acid and clinical parameters in patients with myofascial pain syndrome. J Back Musculoskelet Rehabil. 2010;23(4):187–91.

    PubMed  CAS  Google Scholar 

  99. Andres E, Loukili NH, Noel E, Kaltenbach G, Abdelgheni MB, Perrin AE, et al. Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ. 2004;171(3):251–9.

    Article  PubMed  Google Scholar 

  100. Hallberg L, Hulthen L. Perspectives on iron absorption. Blood Cells Mol Dis. 2002;29(3):562–73.

    Article  PubMed  Google Scholar 

  101. Kotagal S, Silber MH. Childhood-onset restless legs syndrome. Ann Neurol. 2004;56(6): 803–7.

    Article  PubMed  Google Scholar 

  102. Mascarenhas R, Mobarhan S. Hypovitaminosis D-induced pain. Nutr Rev. 2004;62(9): 354–9.

    Article  PubMed  Google Scholar 

  103. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc. 2003;78(12):1463–70.

    Article  PubMed  Google Scholar 

  104. Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Andersen H, et al. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int. 2000;66(6):419–24.

    Article  PubMed  CAS  Google Scholar 

  105. de Rezende Pena C, Grillo LP, das Chagas Medeiros MM. Evaluation of 25-hydroxyvitamin D serum levels in patients with fibromyalgia. J Clin Rheumatol. 2010;16(8):365–9.

    PubMed  Google Scholar 

  106. Pamuk ON, Cakir N. The frequency of thyroid antibodies in fibromyalgia patients and their relationship with symptoms. Clin Rheumatol. 2007;26(1):55–9.

    Article  PubMed  Google Scholar 

  107. Boscarino JA. Posttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies. Ann N Y Acad Sci. 2004;1032:141–53.

    Article  PubMed  Google Scholar 

  108. Garrison RL, Breeding PC. A metabolic basis for fibromyalgia and its related disorders: the possible role of resistance to thyroid hormone. Med Hypotheses. 2003;61(2):182–9.

    Article  PubMed  CAS  Google Scholar 

  109. Buskila D, Atzeni F, Sarzi-Puttini P. Etiology of fibromyalgia: the possible role of infection and vaccination. Autoimmun Rev. 2008;8(1):41–3.

    Article  PubMed  Google Scholar 

  110. Hua XY, Svensson CI, Matsui T, Fitzsimmons B, Yaksh TL, Webb M. Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia. Eur J Neurosci. 2005;22(10):2431–40.

    Article  PubMed  Google Scholar 

  111. Hutchinson MR, Northcutt AL, Chao LW, Kearney JJ, Zhang Y, Berkelhammer DL, et al. Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia. Brain Behav Immun. 2008;22(8):1248–56.

    Article  PubMed  CAS  Google Scholar 

  112. Porter NS, Jason LA, Boulton A, Bothne N, Coleman B. Alternative medical interventions used in the treatment and management of myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia. J Altern Complement Med. 2010;16(3):235–49.

    Article  PubMed  Google Scholar 

  113. Bertisch SM, Legedza AR, Phillips RS, Davis RB, Stason WB, Goldman RH, et al. The impact of psychological factors on placebo responses in a randomized controlled trial comparing sham device to dummy pill. J Eval Clin Pract. 2009;15(1):14–9.

    Article  PubMed  Google Scholar 

  114. Fregni F, Kaptchuk TJ, Imamura M, Chien HF, Riberto M, Hsing WT, et al. Re: challenges and recommendations for placebo controls in randomized trials in physical and rehabilitation medicine: a report of the international placebo symposium working group. Am J Phys Med Rehabil. 2010;89(12):1046–7.

    Article  Google Scholar 

  115. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet. 2010;375(9715):686–95.

    Article  PubMed  Google Scholar 

  116. Staud R. Effectiveness of CAM therapy: understanding the evidence. Rheum Dis Clin North Am. 2011;37(1):9–17.

    Article  PubMed  Google Scholar 

  117. Mayhew E, Ernst E. Acupuncture for fibromyalgia – a systematic review of randomized clinical trials. Rheumatology (Oxford). 2007;46(5):801–4.

    Article  CAS  Google Scholar 

  118. Arnold LM, Bradley LA, Clauw DJ, Glass JM, Goldenberg DL. Multidisciplinary care and stepwise treatment for fibromyalgia. J Clin Psychiatry. 2009;69(12):e35.

    Article  PubMed  Google Scholar 

  119. Fontaine KR, Conn L, Clauw DJ. Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Res Ther. 2010;12(2):R55.

    Article  PubMed  Google Scholar 

  120. Busch AJ, Barber KA, Overend TJ, Peloso PM, Schachter CL. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev. 2007;(4):CD003786.

    Google Scholar 

  121. Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO. Exercise treatment for depression: efficacy and dose response. Am J Prev Med. 2005;28(1):1–8.

    Article  PubMed  Google Scholar 

  122. Rooks DS, Gautam S, Romeling M, Cross ML, Stratigakis D, Evans B, et al. Group exercise, education, and combination self-management in women with fibromyalgia: a randomized trial. Arch Intern Med. 2007;167(20):2192–200.

    Article  PubMed  Google Scholar 

  123. Williams DA, Cary MA, Groner KH, Chaplin W, Glazer LJ, Rodriguez AM, et al. Improving physical functional status in patients with fibromyalgia: a brief cognitive behavioral intervention. J Rheumatol. 2002;29(6):1280–6.

    PubMed  Google Scholar 

  124. Thieme K, Flor H, Turk DC. Psychological pain treatment in fibromyalgia syndrome: efficacy of operant behavioural and cognitive behavioural treatments. Arthritis Res Ther. 2006;8(4):R121.

    Article  PubMed  Google Scholar 

  125. Thieme K, Turk DC, Flor H. Responder criteria for operant and cognitive-behavioral treatment of fibromyalgia syndrome. Arthritis Rheum. 2007;57(5):830–6.

    Article  PubMed  Google Scholar 

  126. Giesecke T, Williams DA, Harris RE, Cupps TR, Tian X, Tian TX, et al. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum. 2003;48(10):2916–22.

    Article  PubMed  Google Scholar 

  127. Vandenkerkhof EG, Macdonald HM, Jones GT, Power C, Macfarlane GJ. Diet, lifestyle and chronic widespread pain: results from the 1958 British birth cohort study. Pain Res Manag. 2011;16(2):87–92.

    PubMed  Google Scholar 

  128. Jentoft ES, Kvalvik AG, Mengshoel AM. Effects of pool-based and land-based aerobic exercise on women with fibromyalgia/chronic widespread muscle pain. Arthritis Rheum. 2001;45(1):42–7.

    Article  PubMed  CAS  Google Scholar 

  129. Wang C, Schmid CH, Rones R, Kalish R, Yinh J, Goldenberg DL, et al. A randomized trial of tai chi for fibromyalgia. N Engl J Med. 2010;363(8):743–54.

    Article  PubMed  CAS  Google Scholar 

  130. van Eijk-Hustings Y, Boonen A, Landewe R. A randomized trial of tai chi for fibromyalgia. N Engl J Med. 2010;363(23):2266. author reply 2266–7.

    PubMed  Google Scholar 

  131. Mengshoel AM, Forseth KO, Haugen M, Walle-Hansen R, Forre O. Multidisciplinary approach to fibromyalgia. A pilot study. Clin Rheumatol. 1995;14(2):165–70.

    Article  PubMed  CAS  Google Scholar 

  132. Bailey A, Starr L, Alderson M, Moreland J. A comparative evaluation of a fibromyalgia rehabilitation program. Arthritis Care Res. 1999;12(5):336–40.

    Article  PubMed  CAS  Google Scholar 

  133. Turk DC, Okifuji A, Sinclair JD, Starz TW. Interdisciplinary treatment for fibromyalgia syndrome: clinical and statistical significance. Arthritis Care Res. 1998;11(3):186–95.

    Article  PubMed  CAS  Google Scholar 

  134. Gustafsson M, Ekholm J, Broman L. Effects of a multiprofessional rehabilitation programme for patients with fibromyalgia syndrome. J Rehabil Med. 2002;34(3):119–27.

    Article  PubMed  Google Scholar 

  135. Lemstra M, Olszynski WP. The effectiveness of multidisciplinary rehabilitation in the treatment of fibromyalgia: a randomized controlled trial. Clin J Pain. 2005;21(2):166–74.

    Article  PubMed  Google Scholar 

  136. Suman AL, Biagi B, Biasi G, Carli G, Gradi M, Prati E, et al. One-year efficacy of a 3-week intensive multidisciplinary non-pharmacological treatment program for fibromyalgia patients. Clin Exp Rheumatol. 2009;27(1):7–14.

    PubMed  CAS  Google Scholar 

  137. Rao SG, Bennett RM. Pharmacological therapies in fibromyalgia. Best Pract Res Clin Rheumatol. 2003;17(4):611–27.

    Article  PubMed  CAS  Google Scholar 

  138. Arnold LM, Keck Jr PE, Welge JA. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics. 2000;41(2):104–13.

    Article  PubMed  CAS  Google Scholar 

  139. Carette S, Bell MJ, Reynolds WJ, Haraoui B, McCain GA, Bykerk VP, et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum. 1994;37(1):32–40.

    Article  PubMed  CAS  Google Scholar 

  140. Tofferi JK, Jackson JL, O’Malley PG. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum. 2004;51(1):9–13.

    Article  PubMed  CAS  Google Scholar 

  141. Goldenberg D, Mayskiy M, Mossey C, Ruthazer R, Schmid C. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum. 1996;39(11):1852–9.

    Article  PubMed  CAS  Google Scholar 

  142. Arnold LM, Hess EV, Hudson JI, Welge JA, Berno SE, Keck Jr PE. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med. 2002;112(3):191–7.

    Article  PubMed  CAS  Google Scholar 

  143. Harvey AT, Rudolph RL, Preskorn SH. Evidence of the dual mechanisms of action of venlafaxine. Arch Gen Psychiatry. 2000;57(5):503–9.

    Article  PubMed  CAS  Google Scholar 

  144. Zijlstra TR, Barendregt PJ, van de Laar MAF. Venlafaxine in fibromyalgia: Results of a randomized, placebo-controlled, double-blind trial. Program and abstracts of the American College of Rheumatology 66th Annual Scientific Meeting; New Orleans, Louisiana. Abstract 179. October 2002;25–9.

    Google Scholar 

  145. Mbaya P, Alam F, Ashim S, Bennett D. Cardiovascular effects of high dose venlafaxine XL in patients with major depressive disorder. Hum Psychopharmacol. 2007;22(3):129–33.

    Article  PubMed  CAS  Google Scholar 

  146. Hauser W, Petzke F, Uceyler N, Sommer C. Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis. Rheumatology (Oxford). 2011;50(3):532–43.

    Article  CAS  Google Scholar 

  147. Recla JM. New and emerging therapeutic agents for the treatment of fibromyalgia: an update. J Pain Res. 2010;3:89–103.

    Article  PubMed  CAS  Google Scholar 

  148. Ablin JN, Buskila D. Emerging therapies for fibromyalgia: an update. Expert Opin Emerg Drugs. 2010;15(3):521–33.

    Article  PubMed  CAS  Google Scholar 

  149. Ray WA, Meredith S, Thapa PB, Hall K, Murray KT. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther. 2004;75(3):234–41.

    Article  PubMed  CAS  Google Scholar 

  150. Dooley DJ, Taylor CP, Donevan S, Feltner D. Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission. Trends Pharmacol Sci. 2007;28(2):75–82.

    Article  PubMed  CAS  Google Scholar 

  151. Biasi G, Manca S, Manganelli S, Marcolongo R. Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharmacol Res. 1998;18(1):13–9.

    PubMed  CAS  Google Scholar 

  152. Russell IJ, Kamin M, Bennett RM, Schnitzer TJ, Green JA, Katz WA. Efficacy of tramadol in treatment of pain in fibromyalgia. J Clin Rheumatol. 2000;6(5):250–7.

    Article  PubMed  CAS  Google Scholar 

  153. Bennett RM, Kamin M, Karim R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med. 2003;114(7):537–45.

    Article  PubMed  CAS  Google Scholar 

  154. Reeves RR, Burke RS. Tramadol: basic pharmacology and emerging concepts. Drugs Today (Barc). 2008;44(11):827–36.

    Article  CAS  Google Scholar 

  155. Goldenberg DL, Felson DT, Dinerman H. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum. 1986;29(11):1371–7.

    Article  PubMed  CAS  Google Scholar 

  156. Clark S, Tindall E, Bennett RM. A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis. J Rheumatol. 1985;12(5):980–3.

    PubMed  CAS  Google Scholar 

  157. Sorensen J, Bengtsson A, Backman E, Henriksson KG, Bengtsson M. Pain analysis in patients with fibromyalgia. effects of intravenous morphine, lidocaine, and ketamine. Scand J Rheumatol. 1995;24(6):360–5.

    Article  PubMed  CAS  Google Scholar 

  158. Doverty M, White JM, Somogyi AA, Bochner F, Ali R, Ling W. Hyperalgesic responses in methadone maintenance patients. Pain. 2001;90(1–2):91–6.

    Article  PubMed  CAS  Google Scholar 

  159. Chang G, Chen L, Mao J. Opioid tolerance and hyperalgesia. Med Clin North Am. 2007;91(2):199–211.

    Article  PubMed  CAS  Google Scholar 

  160. Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007;8:27.

    Article  PubMed  Google Scholar 

  161. Moldofsky H, Lue FA, Mously C, Roth-Schechter B, Reynolds WJ. The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study. J Rheumatol. 1996;23(3):529–33.

    PubMed  CAS  Google Scholar 

  162. Gronblad M, Nykanen J, Konttinen Y, Jarvinen E, Helve T. Effect of zopiclone on sleep quality, morning stiffness, widespread tenderness and pain and general discomfort in primary fibromyalgia patients. A double-blind randomized trial. Clin Rheumatol. 1993;12(2):186–91.

    Article  PubMed  CAS  Google Scholar 

  163. Quijada-Carrera J, Valenzuela-Castano A, Povedano-Gomez J, Fernandez-Rodriguez A, Hernanz-Mediano W, Gutierrez-Rubio A, et al. Comparison of tenoxicam and bromazepam in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial. Pain. 1996;65(2–3):221–5.

    Article  PubMed  CAS  Google Scholar 

  164. Russell IJ, Perkins AT, Michalek JE, Oxybate SXB-26 Fibromyalgia Syndrome Study Group. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial. Arthritis Rheum. 2009;60(1):299–309.

    Article  PubMed  CAS  Google Scholar 

  165. Sendur OF, Tastaban E, Turan Y, Ulman C. The relationship between serum trace element levels and clinical parameters in patients with fibromyalgia. Rheumatol Int. 2008;28(11):1117–21.

    Article  PubMed  CAS  Google Scholar 

  166. Soave PM, Conti G, Costa R, Arcangeli A. Magnesium and anaesthesia. Curr Drug Targets. 2009;10(8):734–43.

    Article  PubMed  CAS  Google Scholar 

  167. Mony L, Kew JN, Gunthorpe MJ, Paoletti P. Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential. Br J Pharmacol. 2009;157(8):1301–17.

    Article  PubMed  CAS  Google Scholar 

  168. Russell IJ, Michalek JE, Flechas JD, Abraham GE. Treatment of fibromyalgia syndrome with super malic: a randomized, double blind, placebo controlled, crossover pilot study. J Rheumatol. 1995;22(5):953–8.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pain Medicine, Harvard Vanguard Medical Associates, 133 Brookline Avenue, Boston, MA, 02215, USA

    Joseph F. Audette M.A., M.D.

  2. Harvard Medical School, 133 Brookline Avenue, Boston, MA, 02215, USA

    Joseph F. Audette M.A., M.D.

Authors
  1. Joseph F. Audette M.A., M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Spaulding Rehabiliation Hospital, Nashua Street 125, Boston, 02114, Massachusetts, USA

    Allison Bailey

  2. , Departments of Anesthesia, Neurology, Cr, Beth Israel Deaconness Medical Center, H, One Brookline Place, Suite 105, Brookline, 02445-7294, USA

    Carolyn Bernstein

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Audette, J.F. (2013). Fibromyalgia and Myofascial Pain. In: Bailey, A., Bernstein, C. (eds) Pain in Women. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7113-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-7113-5_3

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-7112-8

  • Online ISBN: 978-1-4419-7113-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation